Literature DB >> 1987444

Thyroid cancer.

O H Clark1, Q Y Duh.   

Abstract

There have been important recent advances in our understanding of the biologic nature of thyroid cancer and in the early diagnosis of the disease. Despite these advances, there is still considerable controversy over the management of thyroid cancer, including the extent of surgery, the indications for the use of iodine-131, the effectiveness of thyroid-stimulating hormone suppression, and the prediction of outcome. In this review, the current status of the diagnosis and management of the various types of thyroid cancer are carefully reviewed and extensively documented.

Entities:  

Mesh:

Year:  1991        PMID: 1987444     DOI: 10.1016/s0025-7125(16)30480-1

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  11 in total

Review 1.  Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects.

Authors:  N J Sarlis
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Retrospective Analysis of Thyroid Cancer Patients.

Authors:  S S Anand; V Sood; P G Kumar; I Sinha; A Kotwal
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  A less invasive, selective, functional neck dissection for papillary thyroid carcinoma.

Authors:  G Ardito; F Rulli; L Revelli; F Moschella; G Galatà; E Giustozzi; F Ardito; A M Farinon
Journal:  Langenbecks Arch Surg       Date:  2005-08-16       Impact factor: 3.445

4.  Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro.

Authors:  T Hoelting; A Zielke; A E Siperstein; O H Clark; Q Y Duh
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

5.  Changing patterns of thyroid carcinoma.

Authors:  B Dijkstra; R S Prichard; A Lee; L M Kelly; P P A Smyth; T Crotty; E W McDermott; A D K Hill; N O'Higgins
Journal:  Ir J Med Sci       Date:  2007-05-08       Impact factor: 1.568

Review 6.  Papillary thyroid cancer.

Authors:  J H Yim; G M Doherty
Journal:  Curr Treat Options Oncol       Date:  2000-10

7.  Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer.

Authors:  H Wanebo; M Coburn; D Teates; B Cole
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

8.  The incidence of bilateral well-differentiated thyroid cancer found at completion thyroidectomy.

Authors:  J L Pasieka; N W Thompson; M K McLeod; R E Burney; M Macha
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

9.  Is level IIb lymph node dissection always necessary in N1b papillary thyroid carcinoma patients?

Authors:  Jandee Lee; Tae-Yon Sung; Kee-Hyun Nam; Woung Youn Chung; Euy-Young Soh; Cheong Soo Park
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

10.  The Art and Science of Thyroid Surgery in the Age of Genomics: 100 years after Theodor Kocher.

Authors:  Seza Gulec
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.